Predictive Biosciences, a Lexington, Mass.-based developer of biomarker and assay technology for cancer diagnostics, has raised $10 million in Series A funding co-led by Highland Capital Partners and IDG Ventures Boston. www.predictivebiosci.com

Related posts:

  1. Transcend Medical Raises $7 Million
  2. A10 Raises $9 Million
  3. Bariatric Partners Raises $12 Million
  4. Softscope Raises $4 Million
  5. CardioMEMS Raises $22.6 Million